Frontlight ResearchEarly access
CompletedPhase 4
NLR and PLR Levels Following PENG Block in Hip Arthroplasty
Key facts
- Who runs it
- Poznan University of Medical Sciences
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 60 people enrolled
- Started
- 16 Jun 2025
- Ended
- 9 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 0.9% Sodium Chloride Injection
- Ropivacaine 0.2% Injectable Solution
- Record updated
- 29 December 2025
Who can take part
- Age
- 60 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients with ASA classification I-III
- Aged 60-100 years
- Who will be scheduled for hip arthroplasty under spinal anesthesia
Who cannot take part
- Take anticoagulant therapy
- Patients who have a history of bleeding diathesis
- History of chronic pain before surgery
- patients unable to assess their pain (dementia)
- patients having an infection in the region of the procedure
- Multiple trauma
- patients operated under general anesthesia
- the patient who does not accept the procedure
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Effect of PENG block on NLR and PLR following hip arthroplasty
The 2 groups in the trial
- Sham blocksPlacebo, for comparison
PENG block with 20ml of 0.9% sodium chloride
Treatment: 0.9% Sodium Chloride Injection
- PENG blockExisting treatment, for comparison
PENG block with 20ml 0f 0.2% ropivacaine
Treatment: Ropivacaine 0.2% Injectable Solution
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pericapsular Nerve Group Block Mitigates Surgical Stress and Enhances Analgesia in Total Hip Arthroplasty: A Randomized Controlled Trial
- Record updated
- 29 December 2025